scholarly journals Fusicoccin: A Chemical Modulator for 14-3-3 Proteins

2021 ◽  
Vol 50 (1) ◽  
pp. 57-67
Author(s):  
Junko Ohkanda
Keyword(s):  
2020 ◽  
Author(s):  
James Frederich ◽  
Ananya Sengupta ◽  
Josue Liriano ◽  
Ewa A. Bienkiewicz ◽  
Brian G. Miller

Fusicoccin A (FC) is a fungal phytotoxin that stabilizes protein–protein interactions (PPIs) between 14-3-3 adapter proteins and their phosphoprotein interaction partners. In recent years, FC has emerged as an important chemical probe of human 14-3-3 PPIs implicated in cancer and neurological diseases. These previous studies have established the structural requirements for FC-induced stabilization of 14-3-3·client phosphoprotein complexes; however, the effect of different 14-3-3 isoforms on FC activity has not been systematically explored. This is a relevant question for the continued development of FC variants because there are seven distinct isoforms of 14-3-3 in humans. Despite their remarkable sequence and structural similarities, a growing body of experimental evidence supports both tissue-specific expression of 14-3-3 isoforms and isoform-specific functions <i>in vivo</i>. Herein, we report the isoform-specificity profile of FC <i>in vitro</i>using recombinant human 14-3-3 isoforms and a focused library of fluorescein-labeled hexaphosphopeptides mimicking the C-terminal 14-3-3 recognition domains of client phosphoproteins targeted by FC in cell culture. Our results reveal modest isoform preferences for individual client phospholigands and demonstrate that FC differentially stabilizes PPIs involving 14-3-3s. Together, these data provide strong motivation for the development of non-natural FC variants with enhanced selectivity for individual 14-3-3 isoforms.


2020 ◽  
Author(s):  
James Frederich ◽  
Ananya Sengupta ◽  
Josue Liriano ◽  
Ewa A. Bienkiewicz ◽  
Brian G. Miller

Fusicoccin A (FC) is a fungal phytotoxin that stabilizes protein–protein interactions (PPIs) between 14-3-3 adapter proteins and their phosphoprotein interaction partners. In recent years, FC has emerged as an important chemical probe of human 14-3-3 PPIs implicated in cancer and neurological diseases. These previous studies have established the structural requirements for FC-induced stabilization of 14-3-3·client phosphoprotein complexes; however, the effect of different 14-3-3 isoforms on FC activity has not been systematically explored. This is a relevant question for the continued development of FC variants because there are seven distinct isoforms of 14-3-3 in humans. Despite their remarkable sequence and structural similarities, a growing body of experimental evidence supports both tissue-specific expression of 14-3-3 isoforms and isoform-specific functions <i>in vivo</i>. Herein, we report the isoform-specificity profile of FC <i>in vitro</i>using recombinant human 14-3-3 isoforms and a focused library of fluorescein-labeled hexaphosphopeptides mimicking the C-terminal 14-3-3 recognition domains of client phosphoproteins targeted by FC in cell culture. Our results reveal modest isoform preferences for individual client phospholigands and demonstrate that FC differentially stabilizes PPIs involving 14-3-3s. Together, these data provide strong motivation for the development of non-natural FC variants with enhanced selectivity for individual 14-3-3 isoforms.


Life Sciences ◽  
1968 ◽  
Vol 7 (14) ◽  
pp. 751-760 ◽  
Author(s):  
A. Ballio ◽  
A. Graniti ◽  
F. Pocchiari ◽  
V. Silano

IUBMB Life ◽  
2013 ◽  
Vol 65 (6) ◽  
pp. 513-517 ◽  
Author(s):  
Lorenzo Camoni ◽  
Sabina Visconti ◽  
Patrizia Aducci
Keyword(s):  

2020 ◽  
Vol 15 (2) ◽  
pp. 305-310 ◽  
Author(s):  
Ananya Sengupta ◽  
Josue Liriano ◽  
Brian G. Miller ◽  
James H. Frederich

2020 ◽  
Author(s):  
James Frederich ◽  
Ananya Sengupta ◽  
Josue Liriano ◽  
Ewa A. Bienkiewicz ◽  
Brian G. Miller

Fusicoccin A (FC) is a fungal phytotoxin that stabilizes protein–protein interactions (PPIs) between 14-3-3 adapter proteins and their phosphoprotein interaction partners. In recent years, FC has emerged as an important chemical probe of human 14-3-3 PPIs implicated in cancer and neurological diseases. These previous studies have established the structural requirements for FC-induced stabilization of 14-3-3·client phosphoprotein complexes; however, the effect of different 14-3-3 isoforms on FC activity has not been systematically explored. This is a relevant question for the continued development of FC variants because there are seven distinct isoforms of 14-3-3 in humans. Despite their remarkable sequence and structural similarities, a growing body of experimental evidence supports both tissue-specific expression of 14-3-3 isoforms and isoform-specific functions <i>in vivo</i>. Herein, we report the isoform-specificity profile of FC <i>in vitro</i>using recombinant human 14-3-3 isoforms and a focused library of fluorescein-labeled hexaphosphopeptides mimicking the C-terminal 14-3-3 recognition domains of client phosphoproteins targeted by FC in cell culture. Our results reveal modest isoform preferences for individual client phospholigands and demonstrate that FC differentially stabilizes PPIs involving 14-3-3s. Together, these data provide strong motivation for the development of non-natural FC variants with enhanced selectivity for individual 14-3-3 isoforms.


Author(s):  
P. Aducci ◽  
A. Ballio ◽  
V. Fogliano ◽  
M. R. Fullone ◽  
M. Marra ◽  
...  

ChemBioChem ◽  
2012 ◽  
Vol 13 (4) ◽  
pp. 566-573 ◽  
Author(s):  
Motoyoshi Noike ◽  
Chengwei Liu ◽  
Yusuke Ono ◽  
Yoshimitsu Hamano ◽  
Tomonobu Toyomasu ◽  
...  
Keyword(s):  

1972 ◽  
Vol 3 (2) ◽  
Author(s):  
M. BRUFANI ◽  
S. CERRINI ◽  
W. FEDELI ◽  
A. VACIAGO
Keyword(s):  

2010 ◽  
Vol 293 (2) ◽  
pp. 198-206 ◽  
Author(s):  
Ingrid J. de Vries-van Leeuwen ◽  
Chantal Kortekaas-Thijssen ◽  
Jean A. Nzigou Mandouckou ◽  
Sjors Kas ◽  
Antonio Evidente ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document